We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Exposure to Tobacco Smoke Detected by Cotinine Test

By LabMedica International staff writers
Posted on 06 Oct 2009
Exposure to tobacco smoke can be detected by a cotinine test, which indicates the quantity of nicotine metabolites in blood and other body fluids.

Cotinine has a longer half-life than nicotine, which is not used as a marker for tobacco smoke exposure. More...
Cotinine has been found to be a reliable marker for smoking status and smoking cessation studies.

The Calbiotech (Spring Valley, CA, USA) cotinine blood test direct enzyme-linked immunosorbant assay (ELISA) kit has been developed for the detection of cotinine in serum and urine. It can also be adapted for other fluids.

The cotinine blood test kit is a solid phase competitive ELISA. The samples and cotinine enzyme conjugate are added to the wells coated with anticotinine antibody. Cotinine in the samples competes with a cotinine enzyme conjugate for binding sites. Unbound cotinine and cotinine enzyme conjugate is then washed off. The substrate is added and the intensity of color is inversely proportional to the concentration of cotinine in the samples.

Calbiotech is a provider of immunoassay products and services. The company offers ELISA, ultra-sensitive chemiluminescent ELISA (lumELISA), and radioimmunoassay (RIA) products, as well as preclinical testing services. The product line includes: endocrine, steroid, fertility, cancer, thyroid and cardiac, infectious disease, growth hormone, allergy, and drug of abuse markers.

Related Links:

Calbiotech



New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automatic CLIA Analyzer
Shine i6000
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.